alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
400 MARYLAND AVE. S.W., WASHINGTON, DC 20202-2600

www.ed.gov

The Department of Education’s mission is to promote student achievement and preparation for global competitiveness

by fostering educational excellence and ensuring equal access.

UNITED STATES DEPARTMENT OF EDUCATION 

OFFICE OF SPECIAL EDUCATION AND REHABILITATIVE SERVICES 

August 17, 2020

Honorable Paul Foster 

Executive Director 

1560 Broadway #1100 

Denver, Colorado 80202 

foster_p@cde.state.co.us 

Dear Executive Director Foster: 

This letter grants final approval under Section 421(b) of the General Education Provisions Act 

for grant awards H027A180020 and H173A180097. 

The Department received your July 28, 2020 request on behalf of the Colorado Department of

Education for a waiver extending the period of availability for Federal fiscal year (FFY) 2018 

Individuals with Disabilities Education Act (IDEA) Part B grant award funds. 

With this approval, the FFY 2018 IDEA Part B grant award funds will be available for obligation 

through September 30, 2021 and may be liquidated through December 30, 2021. 

Please contact your Office of Special Education Programs (OSEP) State Lead, Susan Murray, at 

Susan.Murray@ed.gov if you have any questions. 

Sincerely, 

/s/

Mark Schultz 

Commissioner, Rehabilitation Services Administration. 

Delegated the authority to perform the functions and duties 

of the Assistant Secretary for the Office of Special 

Education and Rehabilitative Services. 

cc: State Director
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
applicable SEC Form and is qualified in its entirety by reference to such
financial statements.
</LEGEND>
<CIK> 0000034285
<NAME> RELIABILITY INCORPORATED
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               MAR-31-1999
<CASH>                                          13,964
<SECURITIES>                                         0
<RECEIVABLES>                                    2,149
<ALLOWANCES>                                         0
<INVENTORY>                                      1,271
<CURRENT-ASSETS>                                18,397
<PP&E>                                          19,981
<DEPRECIATION>                                  10,764
<TOTAL-ASSETS>                                  31,098
<CURRENT-LIABILITIES>                            2,955
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         9,461
<OTHER-SE>                                      17,975
<TOTAL-LIABILITY-AND-EQUITY>                    31,098
<SALES>                                          4,320
<TOTAL-REVENUES>                                 4,320
<CGS>                                            2,759
<TOTAL-COSTS>                                    2,759
<OTHER-EXPENSES>                                 1,979
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               (158)
<INCOME-PRETAX>                                  (260)
<INCOME-TAX>                                         2
<INCOME-CONTINUING>                              (262)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (262)
<EPS-PRIMARY>                                   (0.04)
<EPS-DILUTED>                                   (0.04)
        

</TABLE>
#### The People of the State of New York v. Robert Middleton.

Motion for leave to appeal as a poor person granted insofar as to permit the appeal to be heard on the original record, without printing the same, except that a certified copy of the indictment shall be substituted in place of the original indictment, and upon typewritten or mimeographed appellant’s points, on condition that the appellant serves one copy of the typewritten or mimeographed appellant’s points upon the District Attorney, New York County, and files 6 typewritten or 19 mimeographed copies of appellant’s points, together with the original record, with this court and on the further condition that the appeal be perfected and noticed for argument on or before the March 1961 Term of this court. Anthony F. Marra, Esq., of 100 Centre Street, New York, New York is assigned as counsel for the appellant for the purposes of the appeal. Concur — Botein, P. J., Breitel, Stevens and Eager, JJ.
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                                       <C>
<PERIOD-TYPE>                             9-MOS
<FISCAL-YEAR-END>                         MAY-31-1997
<PERIOD-END>                              MAR-1-1997
<CASH>                                    24,332
<SECURITIES>                              0
<RECEIVABLES>                             14,701
<ALLOWANCES>                              0
<INVENTORY>                               42,447
<CURRENT-ASSETS>                          82,638
<PP&E>                                    150,598
<DEPRECIATION>                            64,396
<TOTAL-ASSETS>                            174,763
<CURRENT-LIABILITIES>                     36,160
<BONDS>                                   0
<PREFERRED-MANDATORY>                     0
<PREFERRED>                               0
<COMMON>                                  176
<OTHER-SE>                                61,023
<TOTAL-LIABILITY-AND-EQUITY>              174,763
<SALES>                                   223,841
<TOTAL-REVENUES>                          223,841
<CGS>                                     177,016
<TOTAL-COSTS>                             198,755
<OTHER-EXPENSES>                          0
<LOSS-PROVISION>                          0
<INTEREST-EXPENSE>                        3,090
<INCOME-PRETAX>                           22,923
<INCOME-TAX>                              8,958
<INCOME-CONTINUING>                       13,965
<DISCONTINUED>                            0
<EXTRAORDINARY>                           0
<CHANGES>                                 0
<NET-INCOME>                              13,965
<EPS-PRIMARY>                             1.17
<EPS-DILUTED>                             1.17
        

</TABLE>
204.7503 Contract clause. Use the clause at 252.204-7021, Contractor Compliance with the Cybersecurity Maturity Model Certification Level Requirement, as follows: ( a ) Until September 30, 2025, in solicitations and contracts or task orders or delivery orders, including those using FAR part 12 procedures for the acquisition of commercial products and commercial services, except for solicitations and contracts or orders solely for the acquisition of commercially available off-the-shelf (COTS) items, if the requirement document or statement of work requires a contractor to have a specific CMMC level. In order to implement a phased rollout of CMMC, inclusion of a CMMC requirement in a solicitation during this time period must be approved by OUSD(A&S).
( b ) On or after October 1, 2025, in all solicitations and contracts or task orders or delivery orders, including those using FAR part 12 procedures for the acquisition of commercial products and commercial services, except for solicitations and contracts or orders solely for the acquisition of COTS items.
[85 FR 61519, Sept. 29, 2020, as amended at 88 FR 6581, Jan. 31, 2023]
----

----

| (1)   | The      Report fully complies with the requirements of section 13(a) or 15(d) of      the Securities Exchange Act of 1934;and |
|-----------------|--------------------------------------------------------------------------------------------------------------------------------|

| (2)   | The      information contained in the Report fairly presents, in all material      respects, the financial condition and results of operations of the      Company. |
|-----------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| /s/      Matthew K.      Rose             |   | /s/     Thomas N.      Hund           |   |
|-------------------------------------------------------------------------------------------------------------------------------------|--------|-------------------------------------------------------------------------------------------------------------|--------|
|  Matthew      K. Rose                                                                                                          |   |  Thomas      N. Hund                                                                                   |   |
| Chairman,      President and Chief Executive Officer                                                                                |   | Executive      Vice President and Chief Financial Officer                                                   |   |

----

----
Exhibit 10.2


                           PVC RESIN SUPPLY AGREEMENT

         THIS PVC RESIN SUPPLY AGREEMENT (this "Agreement") dated as of the
first day of January 2000 is between ** (hereinafter "Seller"), and EAGLE
PACIFIC INDUSTRIES, INC., a Minnesota corporation (hereinafter "Buyer"). Each
of Seller and Buyer is sometimes hereinafter referred to as a "party" and
collectively as parties.

         **


         IN WITNESS WHEREOF, the parties have, by their duly authorized
representatives, signed this Agreement as of the day and year first above
written.


SELLER                                EAGLE PACIFIC INDUSTRIES, INC.


By:__________________________         By: /s/ William Spell

Title:_______________________         Title: Chief Executive Officer


**  The identity of the Seller and terms of this agreement have been filed
    confidentiality with the Commission, and are not being made publicly
    available pursuant to the Company's pending request for confidential
    treatment.
219.270-2 Procedures. ( a ) To comply with section 898 of the National Defense Authorization Act for Fiscal Year 2016 (Pub. L. 114-92), when acquiring religious-related services to be performed on a U.S. military installation— ( 1 ) Do not preclude a nonprofit organization from competing, even when the acquisition is set aside for small businesses as identified in FAR 19.000(a)(3); and
( 2 ) Do not use any of the sole source exceptions at FAR 6.302-5(b)(4) through (7) for such acquisitions.
( b ) If the apparently successful offeror has not represented in its quotation or offer that it is one of the small business concerns identified in FAR 19.000(a)(3), the contracting officer shall verify that the offeror is registered in the System for Award Management database as a nonprofit organization.
#### 1414.404 Rejection of bids.
[Federal Register Volume 86, Number 15 (Tuesday, January 26, 2021)]
[Notices]
[Page 7101]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-01559]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Limited Competition: Stimulating 
Access to Research in Residency Transition Scholar (StARRTS) (K38) 
(Clinical Trial Not Allowed).
    Date: February 26, 2021.
    Time: 3:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3F30A, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Ellen S. Buczko, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3F30A 
Rockville, MD 20852, (240) 669-5028, <a href="/cdn-cgi/l/email-protection#f6939483958c9d99c7b6989f979f92d8989f9ed8919980"><span class="__cf_email__" data-cfemail="335651465049585c02735d5a525a571d5d5a5b1d545c45">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: January 19, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-01559 Filed 1-25-21; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
This restated financial data schedule contains summary financial information
extracted from The Burlington Northern and Santa Fe Railway Company's
Consolidated Financial Statements and is qualified in its entirety by reference
to such financial statements.
</LEGEND>
<RESTATED>
<CIK> 0000015511
<NAME> THE BURLINGTON NORTHERN AND SANTA FE RAILWAY COMPANY
<MULTIPLIER> 1,000,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               MAR-31-1999
<CASH>                                             103
<SECURITIES>                                         0
<RECEIVABLES>                                      548
<ALLOWANCES>                                        66
<INVENTORY>                                        247
<CURRENT-ASSETS>                                 1,170
<PP&E>                                          25,946
<DEPRECIATION>                                   5,174
<TOTAL-ASSETS>                                  22,910
<CURRENT-LIABILITIES>                            2,194
<BONDS>                                          4,726
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                       8,481
<TOTAL-LIABILITY-AND-EQUITY>                    22,910
<SALES>                                              0
<TOTAL-REVENUES>                                 2,182<F1>
<CGS>                                                0
<TOTAL-COSTS>                                    1,702<F1>
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  76
<INCOME-PRETAX>                                    403
<INCOME-TAX>                                       151
<INCOME-CONTINUING>                                252
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       252
<EPS-BASIC>                                          0
<EPS-DILUTED>                                        0
<FN>
<F1>Restatement reflected herein is the result of reclassifications to prior
periods' financial statements to conform to the current period presentation.
</FN>


</TABLE>
<TABLE> <S> <C>


<ARTICLE>                                           5
<LEGEND>
This Schedule contains summary consolidated financial information extracted from
Form 10-KSB at August 31, 2000 and is qualified in its entirety by reference to
such consolidated financial statements.
</LEGEND>
<MULTIPLIER>                                        1000

<S>                                                 <C>
<PERIOD-TYPE>                                       12-MOS
<FISCAL-YEAR-END>                                   AUG-31-2000
<PERIOD-START>                                      SEP-1-1999
<PERIOD-END>                                        AUG-31-2000
<CASH>                                              3,251
<SECURITIES>                                        0
<RECEIVABLES>                                       0
<ALLOWANCES>                                        0
<INVENTORY>                                         0
<CURRENT-ASSETS>                                    3,280
<PP&E>                                              13
<DEPRECIATION>                                      3
<TOTAL-ASSETS>                                      3,290
<CURRENT-LIABILITIES>                               35
<BONDS>                                             0
<COMMON>                                            34
<PREFERRED-MANDATORY>                               0
<PREFERRED>                                         0
<OTHER-SE>                                          4,774
<TOTAL-LIABILITY-AND-EQUITY>                        3,290
<SALES>                                             0
<TOTAL-REVENUES>                                    144
<CGS>                                               0
<TOTAL-COSTS>                                       647
<OTHER-EXPENSES>                                    0
<LOSS-PROVISION>                                    0
<INTEREST-EXPENSE>                                  0
<INCOME-PRETAX>                                     (503)
<INCOME-TAX>                                        0
<INCOME-CONTINUING>                                 (503)
<DISCONTINUED>                                      0
<EXTRAORDINARY>                                     0
<CHANGES>                                           0
<NET-INCOME>                                        (503)
<EPS-BASIC>                                         (0.18)
<EPS-DILUTED>                                       (0.18)


</TABLE>
Case: 1:12-cv-03671 Document #: 65 Filed: 01/14/14 Page 1 of 3 PageID #:594
Case: 1:12-cv-03671 Document #: 65 Filed: 01/14/14 Page 2 of 3 PageID #:595
Case: 1:12-cv-03671 Document #: 65 Filed: 01/14/14 Page 3 of 3 PageID #:596
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               SEP-30-1999
<CASH>                                          83,214
<SECURITIES>                                         0
<RECEIVABLES>                                2,227,704
<ALLOWANCES>                                  (30,763)
<INVENTORY>                                  1,572,247
<CURRENT-ASSETS>                             4,334,012
<PP&E>                                       3,126,413
<DEPRECIATION>                               1,546,646
<TOTAL-ASSETS>                               7,479,547
<CURRENT-LIABILITIES>                        4,660,792
<BONDS>                                      1,159,270
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        11,523
<OTHER-SE>                                   1,443,673
<TOTAL-LIABILITY-AND-EQUITY>                 7,479,547
<SALES>                                      8,644,642
<TOTAL-REVENUES>                             8,644,642
<CGS>                                        6,221,941
<TOTAL-COSTS>                                6,221,941
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                14,747
<INTEREST-EXPENSE>                             234,430
<INCOME-PRETAX>                              (162,692)
<INCOME-TAX>                                  (55,000)
<INCOME-CONTINUING>                          (107,692)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (107,692)
<EPS-BASIC>                                      (.07)
<EPS-DILUTED>                                    (.07)


</TABLE>
Exhibit 32.0

# Written Statement of
the Chief Executive Officer and Chief Financial OfficerPursuant to 18 U.S.C.
§1350

Solely
for the purposes of complying with 18 U.S.C. §1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002, we, the undersigned Chief Executive Officer and
Chief Financial Officer of Cal-Maine Foods Inc. (the Company), hereby certify,
based on their knowledge, that the Amended Quarterly Report on Form 10-Q of the Company
for the quarter ended November 29, 2003 (the Report) fully complies with the
requirements of Section 13(a) of the Securities Exchange Act of 1934 and that information
contained in the Report fairly presents, in all material respects, the financial condition
and results of operations of the Company.

/s/ Fred R. Adams, Jr.
Fred R. Adams, Jr.Chairman of the Board and Chief Executive Officer

/s/ Bobby J. Raines            Bobby
J. RainesVice President, Chief Financial Officer, Treasurer and Secretary

Date: January 20, 2004
**States with Faith-Based Exemption (31):**

Alabama

Alaska 

Arizona

Arkansas

Colorado

California

Florida

Georgia

Hawaii

Idaho

Illinois

Indiana

Iowa

Louisiana

Maryland

Minnesota

Missouri

New Mexico

New York

North Carolina

Ohio

Oklahoma

Oregon

South Carolina

South Dakota 

Texas

Utah 

Virginia

Washington

Wisconsin

Wyoming

**States without Faith-Based Exemption (21):**

Connecticut

Delaware

District of Columbia

Kansas

Kentucky

Maine

Massachusetts

Michigan

Mississippi

Montana

Nebraska

Nevada

New Hampshire

New Jersey

North Dakota

Pennsylvania

Puerto Rico

Rhode Island

Tennessee

Vermont

West Virginia

**Faith Based Exemption by State**

**Other -  Faith Based Exemption - Not Confirmed (7):**

Virgin Islands

Guam

American Samoa

Marshall Islands

Micronesia

Northern Mariana Islands

Palau
S. Con. Res. 23 Agreed to September 12, 2017

One Hundred Fifteenth Congress 

of the 

United States of America 

AT THE FIRST SESSION 

Begun and held at the City of Washington on Tuesday, 

the third day of January, two thousand and seventeen 

Concurrent Resolution 

Resolved by the Senate (the House of Representatives concurring), 

SECTION 1. USE OF EMANCIPATION HALL FOR CEREMONY TO 

PRESENT THE CONGRESSIONAL GOLD MEDAL TO THE 

FILIPINO VETERANS OF WORLD WAR II. 

(a) AUTHORIZATION.—Emancipation Hall in the Capitol Visitor 

Center is authorized to be used on October 25, 2017 for a ceremony 

to present the Congressional Gold Medal collectively to the Filipino 

Veterans of World War II in recognition of their dedicated military 

service. 

(b) PREPARATIONS.—Physical preparations for the conduct of 

the ceremony described in subsection (a) shall be carried out in 

accordance with such conditions as may be prescribed by the 

Architect of the Capitol. 

Attest: 

Secretary of the Senate. 

Attest: 

Clerk of the House of Representatives.
#### 1332.702-70 Forms.

Contracting officers must obtain an electronic or hardcopy procurement request form on which the availability of adequate funds have been certified by a designated certifying officer. This form must have the name of the certifying official and the certified available funds, as well as the technical and other specifications of the request, administrative approvals, clearances, and information for processing payment.